(Q85037930)
Statements
Randomized placebo-controlled phase II trial of perifosine plus capecitabine as second- or third-line therapy in patients with metastatic colorectal cancer (English)
Johanna C Bendell
John Nemunaitis
Sasha J Vukelja
Christopher Hagenstad
Luis T Campos
Robert C Hermann
Peter Sportelli
Lesa Gardner
Donald A Richards
3 October 2011